Glucose-Dependent Insulinotropic Peptide

FDA approves three treatments for diabetes
FDA approves three treatments for diabetes
Jan 30, 2013

Takeda announced that the FDA has approved Nesina (alogliptin), Oseni (alogliptin and Pioglitazone), and Kazano (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts...